Skip to main content
Caplight Logo









Silver Spur Therapeutics

Silver Spur Therapeutics

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://silverspurtx.com/

Last Round

Accelerator

Jun 17, 2025

Total Funding Raised

$440,000

Company Overview

Silver Spur Therapeutics is a biotechnology company that develops a proprietary nanomedicine delivery platform using peptide amphiphile micelles to target kidney and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanotherapeutic deliverynanomedicinepeptide amphiphile micellesPAMsdrug delivery platformgene therapy deliveryrenal-targeted therapyRNA therapeuticsprecision medicinetargeted drug deliverybiotech startuppreclinical biotechADPKD treatmentdrug delivery techbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Silver Spur Therapeutics Comparables

Compare Silver Spur Therapeutics with similar companies based on industry and business-model similarity.

Silver Spur Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeal Therapeutics, Inc.
86%
Nephrogen
81%
Judo Bio
77%

Silver Spur Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 17, 2025
AcceleratorJun 17, 2025
AcceleratorMar 10, 2025

Key People

Founding team and executive leadership

Yi HUANG

Chief Technology Officer

Executive Team

Silver Spur Therapeutics Investors

Notable investors and investment history

Silver Spur Therapeutics investors
InvestorRounds
TechstarsAccelerator
StoryHouse VenturesAccelerator
University of Southern CaliforniaAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2025

    $220K round led by Techstars

Silver Spur Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Silver Spur Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Silver Spur Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range3
Year Founded2023
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?